Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Genetic Technologies Ltd (GENE)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Genetic Technologies's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
3.150 0.000    0.00%
09:33:30 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 1,284
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 3.150 - 3.160
Genetic Technologies 3.150 0.000 0.00%

GENE Income Statement

 
Featured here, the Income Statement (earnings report) for Genetic Technologies Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Collapse All
Period Ending: 2023
31/12
 2023
30/09
 2023
30/06
 2023
31/03
Total Revenue 2.48 2.48 2.69 2.69
Revenue 1.98 1.98 2.27 2.27
Other Revenue, Total 0.502 0.502 0.419 0.419
Cost of Revenue, Total 0.878 0.878 1.09 1.09
Gross Profit 1.6 1.56 1.59 1.59
Total Operating Expenses 5.02 5.02 5.2 5.2
Selling/General/Admin. Expenses, Total 2.9 2.9 2.62 2.62
Research & Development 0.195 0.195 0.361 0.361
Depreciation / Amortization 0.14 0.14 -0.165 -0.165
Interest Expense (Income) - Net Operating -0.006 -0.006 -0.007 -0.007
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 0.914 0.914 1.29 1.29
Operating Income -2.54 -2.54 -2.51 -2.51
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - - - -
Other, Net 0.673 0.673 0.638 0.638
Net Income Before Taxes -3.21 -3.21 -3.15 -3.15
Provision for Income Taxes - - -0.005 -0.005
Net Income After Taxes -3.21 -3.21 -3.15 -3.15
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items -3.21 -3.21 -3.15 -3.15
Total Extraordinary Items - - - -
Net Income -3.21 -3.21 -3.15 -3.15
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items -3.21 -3.21 -3.15 -3.15
Dilution Adjustment - - - -
Diluted Net Income -3.21 -3.21 -3.15 -3.15
Diluted Weighted Average Shares 115.45 115.45 110.42 110.42
Diluted EPS Excluding Extraordinary Items -0.028 -0.028 -0.028 -0.028
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS -0.014 -0.014 -0.013 -0.013
* In Millions of AUD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

GENE Comments

Write your thoughts about Genetic Technologies Ltd
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mr Risk
Mr Risk May 28, 2021 3:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Trading halt on ASX for GTG (the underlying stock of GENE) today - waiting for announcement regardig the Covid-19 risk test.
Reply
2 0
Report
Mr Risk
Mr Risk May 28, 2021 3:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Trading halt expires 1st of June. Expect a statement from the company before this time.
Reply
0 0
Report
Mr Risk
Mr Risk May 28, 2021 3:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
As expected. The Covid-19 test is now available via their US partner via Medicare and Mediaid.
Reply
0 0
Report
Mr Risk
Mr Risk Apr 29, 2021 11:35AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Commercial release of Covid19 risk test announced to be ready in US market before end of May.
Reply
3 0
Report
Mr Risk
Mr Risk Apr 12, 2021 2:19PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
In the meantime - watch out for a coming spike when they launch their integration towards Medicare and Medicaid for their Covid-19 risk assessment test.
Reply
2 0
Report
Mr Risk
Mr Risk Apr 12, 2021 2:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
If only GENE could make a gene-test that would tell if a patient will get an adverser reaction to the AstraZeneca vaccine towards Covid-19 - then they would have a winner!
Reply
2 0
Report
Mr Risk
Mr Risk Apr 09, 2021 10:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Finally - getting closer to the launch of Covid-19 Risk test in the US market. See announcement today
Reply
4 0
Report
Bruno Alves
Bruno Alves Apr 08, 2021 3:47AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
1617868017_53922.jpg
Nice... :)
Reply
2 0
Report
Mr Risk
Mr Risk Mar 12, 2021 11:02AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Whats up?
Reply
0 0
Report
Benjamin Kim
Benjamin Kim Mar 12, 2021 11:02AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
oversold
Reply
2 0
Report
Mr Risk
Mr Risk Mar 04, 2021 8:41AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
seems like the market in general did not get the story about the distribution agreement for USA for the Covid-19 risk test.
Reply
2 1
Report
Casa Albufeira
Casa Albufeira Mar 04, 2021 8:41AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
untill the next earning report day...
Reply
1 0
Report
Karen Sch
Karen Sch Mar 03, 2021 1:54AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
There is good news on GENE's website!
Reply
1 0
Report
Pira Mahendran
BrunoP_Silva Mar 02, 2021 10:21AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Trade is stopped by the company. News will coming...
Reply
0 0
Report
Casa Albufeira
Casa Albufeira Mar 02, 2021 10:21AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
good or bad news?
Reply
0 0
Report
Pira Mahendran
BrunoP_Silva Mar 02, 2021 10:21AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Casa Albufeira  The want  announce in relation to a material distribution agreement. So good news. See Link:https://hotcopper.com.au/threads/ann-trading-halt.5938772/
Reply
0 0
Report
Casa Albufeira
Casa Albufeira Mar 02, 2021 10:21AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Pira Mahendran  muito obrigado..
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email